Routine screening of splenic or portal vein thrombosis after splenectomy

Affiliation auteurs!!!! Error affiliation !!!!
TitreRoutine screening of splenic or portal vein thrombosis after splenectomy
Type de publicationJournal Article
Year of Publication2017
AuteursBouvier A., Gout M., Audia S., Chalumeau C., Rat P., Deballo O.
JournalREVUE DE MEDECINE INTERNE
Volume38
Pagination3-7
Date PublishedJAN
Type of ArticleArticle
ISSN0248-8663
Mots-clésPortal vein thrombosis, Screening, splenectomy, Splenic vein thrombosis
Résumé

Background. - Portal and/or splenic vein thrombosis (PSVT) is common after splenectomy. It can be a life-threatening complication, with a risk of bowel ischemia and portal hypertension. An early diagnosis allows an effective medical treatment and prevents life-threatening complications. There is no consensus regarding the benefit of systematic screening of patients after splenectomy for PSVT. We started in January 2012 a routine screening of PSVT after elective splenectomy. The aim of this study was to assess this policy. Methods. - Since January 2012, all patients undergoing an elective splenectomy had an abdominal CT-scan on postoperative-day 7. Demographic data, pathology, type of surgery, platelet counts before and after surgery, outcome, results of medical imaging, and management of PSVT and its results were recorded. Results. - Over 3 years, 52 patients underwent an elective splenectomy. All of them had a CT-scan at postoperative-day 7. A PSVT was found in 11 patients (21.2 %). They were all asymptomatic. Lymphoma and splenomegaly were the main factors associated with PSVT in the univariate analysis. All patients with PSVT were treated with anticoagulation and no complication of PSVT occurred. The follow-up CT confirmed the efficacy of anticoagulation therapy in all patients. Conclusions. - Routine screening of PSVT after elective splenectomy is warranted because it allows to start anticoagulant therapy and avoid further life-threatening complications. The incidence of PSVT is particularly high among patients operated on for lymphoma or with splenomegaly. (C) 2016 Societe Nationale Francaise de Medecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

DOI10.1016/j.revmed.2016.08.003